Skip to content
Clinical Trials – home

Hospital Universitario Del Vinalopo

Research site

Spain Calle Tonico Sansano Mora 14, 03293 Elche, Spain

  • 5 trials recruiting
  • Breast cancer female · Embolism venous · Non-small cell lung cancer
  • Adult patients

About Specializations

Hospital Universitario Del Vinalopo in Elche, Spain specialises in clinical trials of conditions such as Breast cancer female, Embolism venous, Non-small cell lung cancer, Adenocarcinoma pancreas, and other specialisations. This site conducts important research.

Main research areas of the site

Diagnostic Imaging and Breast Cancer Research

At Hospital Universitario Del Vinalopo, the Radiology department is actively involved in studies that connect advanced imaging with cancer care, especially in breast cancer. This work focuses on improving diagnosis and helping doctors better understand how imaging findings relate to surgical and pathology results.

  • Breast cancer imaging and surgical correlation
  • Multiparametric MRI and diagnostic value assessment
  • Support for more accurate cancer detection and treatment planning

These trials aim to strengthen diagnostic techniques and refine how imaging can guide care for patients with early and advanced breast cancer.

Cardiovascular and Thromboembolic Studies

The site is also contributing to research in cardiovascular diseases, with a strong focus on acute pulmonary embolism and venous thromboembolism. These studies are designed to evaluate treatment effectiveness and improve outcomes for patients at risk of serious clot-related complications.

  • Acute pulmonary embolism management
  • Venous thromboembolism in patients with cancer
  • Assessment of therapies aimed at reducing recurrence and improving recovery

Research in this area helps clarify which approaches may offer better protection and safer care for patients with complex clotting disorders.

Oncology Trials Across Multiple Cancer Types

A major part of the clinical research portfolio at Hospital Universitario Del Vinalopo centers on neoplasms, including breast cancer, head and neck squamous cell carcinoma, and ROS1-positive non-small cell lung cancer. These studies explore new treatment strategies and test whether combining therapies can improve survival and disease control.

  • Early-stage and metastatic breast cancer
  • Head and neck squamous cell carcinoma
  • Non-small cell lung cancer with brain metastasis

The overall goal is to evaluate more effective cancer treatments while also tracking how tumors respond over time.

Hematology and Blood Disorder Research

The hematology portfolio includes studies in polycythemia vera and chronic myeloid leukemia, reflecting the site’s interest in diseases of the blood and bone marrow. These trials are centered on testing new therapies and understanding how they may help control disease activity and reduce treatment burden.

  • Polycythemia vera symptom and disease control
  • Chronic phase chronic myeloid leukemia treatment response
  • Evaluation of targeted approaches for blood-related cancers

This research supports the search for more precise and better-tolerated options in hemic and lymphatic diseases.

Immune and Kidney Disease Investigations

Clinical trials at the site also extend into immune system diseases and kidney disorders, including primary membranous nephropathy. These studies are intended to assess whether emerging treatments can improve disease control and help protect kidney function.

  • Primary membranous nephropathy
  • Immune-related disease management
  • Testing new therapies for better clinical response

This work broadens the research profile beyond cancer and imaging, showing a wider interest in complex chronic diseases.

Musculoskeletal and Pain Management Research

The site is involved in studies on musculoskeletal diseases, particularly chronic non-specific low back pain. These trials focus on understanding how to improve pain relief when standard non-opioid approaches have not provided enough benefit or are not suitable.

  • Chronic non-specific low back pain
  • Evaluation of pain reduction strategies
  • Support for patients with limited response to prior treatment

The aim is to identify better options for managing persistent pain and improving daily function.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Calle Tonico Sansano Mora 1403293 ElcheSpain
Recruiting now
5 trials
Conditions studied
22

More sites in ElcheSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

20 clinical trials

A Study of Povetacicept Compared to Tacrolimus for Adults with Primary Membranous Nephropathy

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Povetacicept
  • Sponsor:Vertex Pharmaceuticals Inc.

Study of Olverembatinib and Bosutinib for Patients with Chronic Phase Chronic Myeloid Leukemia

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bosutinib
  • Sponsor:Ascentage Pharma Group Inc.

Study on the Safety and Effectiveness of Repotrectinib for Patients with ROS1-Positive Non-Small Cell Lung Cancer and Active Brain Metastasis

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Repotrectinib
  • Sponsor:Medica Scientia Innovation Research S.L.

Study on the Effects of Ficlatuzumab and Cetuximab for Adults with Recurrent or Metastatic HPV-Negative Head and Neck Cancer

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Aveo Pharmaceuticals Inc.

Study on the Effectiveness of Oxygen for Patients with Intermediate-Risk Acute Pulmonary Embolism

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal

Petosemtamab versus cetuximab plus drug combination as first‑line treatment for adults with metastatic left‑sided colorectal cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Genmab A/S

Non-small cell lung cancer

Not yet recruiting

Study of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Immunitybio Inc.

Secondary immunodeficiency

Not yet recruiting

Study of Human Normal Immunoglobulin in Adults with Secondary Immune Deficiency after CAR T‑cell or T‑cell Redirecting Therapy for Hematologic Malignancies

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:CSL Behring LLC

Adenocarcinoma pancreas

Not yet recruiting

First‑Line Study of Zoldonrasib (RMC‑9805) Drug Combination vs Gemcitabine/Nab‑Paclitaxel in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Revolution Medicines Inc.

A Phase III Randomized Trial of Trilaciclib Dihydrochloride versus Placebo in Adults with Limited‑Stage Small Cell Lung Cancer

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Pharmacosmos A/S

Study on the Effectiveness of Abemaciclib, Inavolisib, and Giredestrant in Patients with Early HR-positive/HER2-negative Breast Cancer

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Medica Scientia Innovation Research S.L.

Back pain

Not recruiting

Study on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dronabinol
  • Sponsor:Vertanical GmbH
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.